Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment

Ntari, L; Nikolaou, C; Kranidioti, K; Papadopoulou, D; Christodoulou-Vafeiadou, E; Chouvardas, P; Meier, F; Geka, C; Denis, MC; Karagianni, N; Kollias, G

Kollias, G (corresponding author), Biomed Sci Res Ctr BSRC, Inst Bioinnovat, 34 Alexander Fleming St, Vari 16672, Greece.

JOURNAL OF TRANSLATIONAL MEDICINE, 2021; 19 (1):

Abstract

Background New medications for Rheumatoid Arthritis (RA) have emerged in the last decades, including Disease Modifying Antirheumatic Drugs (DMARDs) an......

Full Text Link